48 related articles for article (PubMed ID: 27046514)
21. Intraprocedural blood volume measurement using C-arm CT as a predictor for treatment response of malignant liver tumours undergoing repetitive transarterial chemoembolization (TACE).
Vogl TJ; Schaefer P; Lehnert T; Nour-Eldin NE; Ackermann H; Mbalisike E; Hammerstingl R; Eichler K; Zangos S; Naguib NN
Eur Radiol; 2016 Mar; 26(3):755-63. PubMed ID: 26123407
[TBL] [Abstract][Full Text] [Related]
22. C-arm flat detector computed tomography parenchymal blood volume imaging: the nature of parenchymal blood volume parameter and the feasibility of parenchymal blood volume imaging in aneurysmal subarachnoid haemorrhage patients.
Kamran M; Byrne JV
Neuroradiology; 2015 Sep; 57(9):937-49. PubMed ID: 26022353
[TBL] [Abstract][Full Text] [Related]
23. Parenchymal Blood Volume Assessed by C-Arm-Based Computed Tomography in Immediate Posttreatment Evaluation of Drug-Eluting Bead Transarterial Chemoembolization in Hepatocellular Carcinoma.
Syha R; Grözinger G; Grosse U; Maurer M; Zender L; Horger M; Nikolaou K; Ketelsen D
Invest Radiol; 2016 Feb; 51(2):121-6. PubMed ID: 26488373
[TBL] [Abstract][Full Text] [Related]
24. Image quality of arterial phase and parenchymal blood volume (PBV) maps derived from C-arm computed tomography in the evaluation of transarterial chemoembolization.
Zitzelsberger T; Syha R; Grözinger G; Partovi S; Nikolaou K; Grosse U
Cancer Imaging; 2018 May; 18(1):16. PubMed ID: 29720249
[TBL] [Abstract][Full Text] [Related]
25. Endpoints and cutpoints in head and neck oncology trials: methodical background, challenges, current practice and perspectives.
Hezel M; von Usslar K; Kurzweg T; Lörincz BB; Knecht R
Eur Arch Otorhinolaryngol; 2016 Apr; 273(4):837-44. PubMed ID: 25573834
[TBL] [Abstract][Full Text] [Related]
26. Lung radiofrequency and microwave ablation: a review of indications, techniques and post-procedural imaging appearances.
Smith SL; Jennings PE
Br J Radiol; 2015 Feb; 88(1046):20140598. PubMed ID: 25465192
[TBL] [Abstract][Full Text] [Related]
27. [Is there a curative treatment for oligometastases? Lung radiofrequency ablation].
Palussière J; Descat E; Cornélis F
Cancer Radiother; 2012 Sep; 16(5-6):348-50. PubMed ID: 22921982
[TBL] [Abstract][Full Text] [Related]
28. Tumor response assessments with diffusion and perfusion MRI.
Li SP; Padhani AR
J Magn Reson Imaging; 2012 Apr; 35(4):745-63. PubMed ID: 22434697
[TBL] [Abstract][Full Text] [Related]
29. Multifunctional profiling of non-small cell lung cancer using 18F-FDG PET/CT and volume perfusion CT.
Sauter AW; Winterstein S; Spira D; Hetzel J; Schulze M; Mueller M; Pfannenberg C; Claussen CD; Klotz E; Hann von Weyhern C; Horger MS
J Nucl Med; 2012 Apr; 53(4):521-9. PubMed ID: 22414637
[TBL] [Abstract][Full Text] [Related]
30. New CT response criteria in non-small cell lung cancer: proposal and application in EGFR tyrosine kinase inhibitor therapy.
Lee HY; Lee KS; Ahn MJ; Hwang HS; Lee JW; Park K; Ahn JS; Kim TS; Yi CA; Chung MJ
Lung Cancer; 2011 Jul; 73(1):63-9. PubMed ID: 21093094
[TBL] [Abstract][Full Text] [Related]
31. New Response Evaluation Criteria in Solid Tumors (RECIST) guidelines for advanced non-small cell lung cancer: comparison with original RECIST and impact on assessment of tumor response to targeted therapy.
Nishino M; Jackman DM; Hatabu H; Yeap BY; Cioffredi LA; Yap JT; Jänne PA; Johnson BE; Van den Abbeele AD
AJR Am J Roentgenol; 2010 Sep; 195(3):W221-8. PubMed ID: 20729419
[TBL] [Abstract][Full Text] [Related]
32. Imaging techniques to evaluate the response to treatment in oncology: current standards and perspectives.
Marcus CD; Ladam-Marcus V; Cucu C; Bouché O; Lucas L; Hoeffel C
Crit Rev Oncol Hematol; 2009 Dec; 72(3):217-38. PubMed ID: 18760935
[TBL] [Abstract][Full Text] [Related]
33. Transpulmonary chemoembolization (TPCE) as a treatment for unresectable lung metastases.
Vogl TJ; Lehnert T; Zangos S; Eichler K; Hammerstingl R; Korkusuz H; Lindemayr S
Eur Radiol; 2008 Nov; 18(11):2449-55. PubMed ID: 18553086
[TBL] [Abstract][Full Text] [Related]
34. Radiologic measurements of tumor response to treatment: practical approaches and limitations.
Suzuki C; Jacobsson H; Hatschek T; Torkzad MR; Bodén K; Eriksson-Alm Y; Berg E; Fujii H; Kubo A; Blomqvist L
Radiographics; 2008; 28(2):329-44. PubMed ID: 18349443
[TBL] [Abstract][Full Text] [Related]
35. Superselective transcatheter arterial chemoembolisation of an unresectable hepatocellular carcinoma using three-dimensional rotational angiography.
Takao H; Doi I; Watanabe T
Br J Radiol; 2007 May; 80(953):e85-7. PubMed ID: 17638836
[TBL] [Abstract][Full Text] [Related]
36. Treatment of unresectable lung metastases with transpulmonary chemoembolization: preliminary experience.
Vogl TJ; Wetter A; Lindemayr S; Zangos S
Radiology; 2005 Mar; 234(3):917-22. PubMed ID: 15681689
[TBL] [Abstract][Full Text] [Related]
37. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003.
Pfister DG; Johnson DH; Azzoli CG; Sause W; Smith TJ; Baker S; Olak J; Stover D; Strawn JR; Turrisi AT; Somerfield MR;
J Clin Oncol; 2004 Jan; 22(2):330-53. PubMed ID: 14691125
[No Abstract] [Full Text] [Related]
38. Surgical treatment for pulmonary metastases.
Van Schil PE
Acta Clin Belg; 2002; 57(6):333-9. PubMed ID: 12723252
[TBL] [Abstract][Full Text] [Related]
39. Interactive three-dimensional volume rendering of spiral CT data: current applications in the thorax.
Johnson PT; Fishman EK; Duckwall JR; Calhoun PS; Heath DG
Radiographics; 1998; 18(1):165-87. PubMed ID: 9460115
[TBL] [Abstract][Full Text] [Related]
40. [The chemoembolization of hepatocellular carcinoma: the computed tomographic findings and clinical results in prospective repetitive therapy].
Huppert PE; Geissler F; Duda SH; Lauchart W; Dette S; Dietz K; Brambs HJ; Claussen CD
Rofo; 1994 May; 160(5):425-32. PubMed ID: 7513560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
